Zobrazeno 1 - 3
of 3
pro vyhledávání: '"556"'
Autor:
Xiaojia Wang, Zefei Jiang, Guyin Lou, Biyun Wang, Zhongsheng Tong, Binghe Xu, Jianfeng Luo, Y. Pan, Zhimin Shao, Yongmei Yin, Li Cai, Changping Wu, Donggeng Liu, Jifeng Feng, Y. Teng, Zhonghua Wang, Joseph Ragaz, Jian Zhang, Xichun Hu, Jiong Wu
Publikováno v:
Cancer Research. 75:P3-10
Background: There is still no standard chemotherapy for patients with metastatic triple-negative breast cancer (mTNBC). Our previous phase II pilot trial with first-line gemcitabine and cisplatin combination (GP) in patients with mTNBC (clinicaltrial
Autor:
Giampaolo Bianchini, L. Gianni, William Fraser Symmans, Milvia Zambetti, Takayuki Iwamoto, L Pusztai, Catherine M. Kelly, G Del Conte, Libero Santarpia, Angelica Fasolo
Publikováno v:
Cancer Research. 71:S1-7
Background Used upfront or after 2 to 3 years (yrs) of tamoxifen (TAM) or as extended treatment after 5 yrs of TAM, aromatase inhibitors (AIs) are associated with less recurrences than with 5 yrs of TAM. However, up front AIs were not superior to TAM
Autor:
I Bedrosian, DZ L'Heureux, Y-Ct Shih, Christopher Comstock, VJ Suman, Twf Yen, Constantine Gatsonis, K Yao, E Kim, R Birdwell, Gillian M. Newstead
Publikováno v:
Cancer Research. 71:OT2-05
Background Surgical planning and local-regional treatment of breast cancer relies on accurate assessment of disease extent including the primary tumor size and the presence/absence of multiple tumor foci. As a staging modality for breast cancer, MRI